Preparation and in vivo evaluation of surface heparinized small diameter tissue engineered vascular scaffolds of poly(ε-caprolactone) embedded with collagen suture
Restricted accessResearch articleFirst published online January, 2020
Preparation and in vivo evaluation of surface heparinized small diameter tissue engineered vascular scaffolds of poly(ε-caprolactone) embedded with collagen suture
Herein biodegradable poly(ε-caprolactone) was electrospun into tubular microfibrous scaffolds and modified by the surface heparinization and wrapping of Type I collagen suture for enhancing anticoagulation activity and mechanical properties. The resulting scaffolds were featured by a double distribution of microfiber diameters ranged in 2.74 ± 0.44 and 5.15 ± 0.63 µm on the outer surface with tensile strength of 1.36 ± 0.37 MPa and Young’s modulus of 8.31 ± 1.87 MPa. The burst pressure after embedded with collagen suture was increased to 2419 ± 121 mmHg, remarkably higher than that of the poly(ε-caprolactone)-only scaffolds (1500 ± 136 mmHg) and native vessels. The scaffolds were evaluated in six rabbits for 20 weeks via a carotid artery interpositional model demonstrating a good patency. The effective cell infiltration, and rapid endothelialization and smooth muscle cell maturation were observed. There was no calcification in 20 weeks, and only one developed the aneurysm dilation after 16 weeks. It suggested that the surface heparinization is beneficial to improve the hydrophilicity and anticoagulation property of scaffolds, and embedment of collagen suture is useful to reinforce the mechanical properties and burst pressure.
NaitoYShinokaTDuncanD, et al.
Vascular tissue engineering: towards the next generation vascular grafts. Adv Drug Deliv Rev2011;
63: 312–323.
4.
LiSSenguptaDChienS.Vascular tissue engineering: from in vitro to in situ. Wiley Interdiscip Rev Syst Biol Med2014;
6: 61–76.
5.
SeifalianAMTiwariAHamiltonG, et al.
Improving the clinical patency of prosthetic vascular and coronary bypass grafts: the role of seeding and tissue engineering. Art Organs2015;
26: 307–320.
6.
ChaparroFJMatusickyMEAllenMJ, et al.
Biomimetic microstructural reorganization during suture retention strength evaluation of electrospun vascular scaffolds. J Biomed Mater Res Part Res2016;
104: 1525–1534.
7.
MiHYJingXMcnultyJ, et al.
Approaches to fabricating multiple-layered vascular scaffolds using hybrid electrospinning and thermally induced phase separation methods. Ind Eng Chem Res2016;
55: 882–892.
8.
JuYMAhnHArenas-HerreraJ, et al.
Electrospun vascular scaffold for cellularized small diameter blood vessels: a preclinical large animal study. Acta Biomater2017;
59: 58–67.
9.
LiuYJiangCLiS, et al.
Composite vascular scaffold combining electrospun fibers and physically-crosslinked hydrogel with copper wire-induced grooves structure. J Mech Behav Biomed Mater2016;
61: 12–25.
10.
GuiLZhaoLSpencerRW, et al.
Development of novel biodegradable polymer scaffolds for vascular tissue engineering. Tissue Eng Part A2011;
17: 1191.
PrabhakarVAlarconGJ.Engineering porcine arteries: effects of scaffold modification. J Biomed Mater Res A2010;
67A: 303–311.
13.
MengZXWangYSMaC, et al.
Electrospinning of PLGA/gelatin randomly-oriented and aligned nanofibers as potential scaffold in tissue engineering. Mater Sci Eng C2010;
30: 1204–1210.
14.
YangCWuXZhaoY, et al.
Nanofibrous scaffold prepared by electrospinning of poly(vinyl alcohol)/gelatin aqueous solutions. J Appl Polym Sci2011;
121: 3047–3055.
15.
ScaffaroRLoprestiFBottaL, et al.
Integration of PCL and PLA in a monolithic porous scaffold for interface tissue engineering. J Mech Behav Biomed Mater2016;
63: 303–313.
16.
ZongCWangMYangF, et al.
A novel therapy strategy for bile duct repair using tissue engineering technique: PCL/PLGA bilayered scaffold with hMSCs. J Tissue Eng Regen Med2017;
11: 966–976.
17.
SiddiquiNAsawaSBirruB, et al.
PCL-based composite scaffold matrices for tissue engineering applications. Mol Biotechnol2018;
60: 1–27.
18.
DingYLiWCorreiaA, et al.
Electrospun phb/pcl/sol-gel derived silica hybrid scaffolds with drug releasing function for bone tissue engineering applications. ACS Appl Mater Interfaces2018;
10: 14540–14548.
19.
LeeSJLiuJOhSH, et al.
Development of a composite vascular scaffolding system that withstands physiological vascular conditions. Biomaterials2008;
29: 2891–2898.
20.
ValenceSDTilleJCMugnaiD, et al.
Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement model. Biomaterials2012;
33: 38–47.
21.
WangZCuiYWangJ, et al.
The effect of thick fibers and large pores of electrospun poly(ε-caprolactone) vascular grafts on macrophage polarization and arterial regeneration. Biomaterials2014;
35: 5700–5710.
22.
CaoJGengXWenJ, et al.
The penetration and phenotype modulation of smooth muscle cells on surface heparin modified poly(ε-caprolactone) vascular scaffold. J Biomed Mater Res A2017;
105: 2806–2815.
23.
YeLCaoJChenL, et al.
The fabrication of double layer tubular vascular tissue engineering scaffold via coaxial electrospinning and its 3D cell coculture. J Biomed Mater Res A2015;
103: 3863–3871.
24.
YeLWuXDuanHY, et al.
The in vitro and in vivo biocompatibility evaluation of heparin-poly(ε-caprolactone) conjugate for vascular tissue engineering scaffolds. J Biomed Mater Res A2012;
100: 3251–3258.
25.
JinXGengXJiaL, et al. Preparation of small‐diameter tissue‐engineered vascular grafts electrospun from heparin end‐capped PCL and evaluation in a rabbit carotid artery replacement model. Macromol Biosci 2019; 19: e1900114. DOI: 10.1002/mabi.201900114.
26.
MulloyBHogwoodJGrayE, et al.
Pharmacology of heparin and related drugs. Pharmacol Rev2016;
68: 76–141.
27.
SinghMBhattDLStoneGW, et al.
Antithrombotic approaches in acute coronary syndromes: optimizing benefit vs bleeding risks. Mayo Clinic Proc2016;
91: 1413–1447.
28.
LorkowskazawickaBKamińskiKCiejkaJ, et al.
Inactivation of heparin by cationically modified chitosan. Mar Drugs2014;
12: 3953–3969.
29.
BjörkILindahlU.Mechanism of the anticoagulant action of heparin. Mol Cell Biochem1982;
48: 161–182.
30.
RadkeDJiaWSharmaD, et al.
Tissue engineering at the blood-contacting surface: a review of challenges and strategies in vascular graft development. Adv Healthcare Mater2018;
7: 1701461.
31.
DuFWangHZhaoW, et al.
Gradient nano-fibrous chitosan/poly ɛ-caprolactone scaffolds as extracellular micro-environments for vascular tissue engineering. Biomaterials2012;
33: 762–770.
32.
ChenYLiDX.Analysis of error for pore structure of porous materials measured by MIP. Bull Chin Ceram Soc2006;
25: 198–201.
33.
ZahedmaneshHMackleJNSellbornA, et al.
Bacterial cellulose as a potential vascular graft: mechanical characterization and constitutive model development. J Biomed Mater Res Part Res2011;
97: 105–113.
34.
LiuYN.Spectrophotometry of toluidine blue method for the calibration curve of heparin. Chin J Spectros Lab2009;
26: 278–280.
35.
YounesiMKnapikDMCumskyJ, et al.
Effects of PDGF-BB delivery from heparinized collagen sutures on the healing of lacerated chicken flexor tendon in vivo. Acta Biomater2017;
63: 200–209.
36.
DimitrievskaSNiklasonLE.Historical perspective and future direction of blood vessel developments. Cold Spring Harb Perspect Med2018;
8: a025742.
37.
PennelTBezuidenhoutDKoehneJ, et al.
Transmural capillary ingrowth is essential for confluent vascular graft Healing. Acta Biomater2018;
65: 237–247.
38.
BrugmansMSerreroACoxM, et al.
Morphology and mechanisms of a novel absorbable polymeric conduit in the pulmonary circulation of sheep. Cardiovasc Pathol2019;
38: 31–38.
39.
BockeriaLASvanidzeOKimA, et al.
Total cavopulmonary connection with a new bioabsorbable vascular graft: first clinical experience. J Thorac Cardiovasc Surg2017;
153: 1542–1550.
40.
WuYQinYWangZ, et al.
The regeneration of macroporous electrospun poly(e-caprolactone) vascular graft during long-term in situ implantation. J Biomed Mater Res Part B Appl Biomater2017;
106: 3251–3258.
41.
ZillaPBezuidenhoutDHumanP.Prosthetic vascular grafts: wrong models, wrong questions and no healing. Biomaterials2007;
28: 5009–5027.
42.
LermanALermanLOBonettiPO.Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol2003;
23: 168–175.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
